CancerYancik R. Ovarian cancer: age contrasts in incidence, histol- ogy, disease stage at diagnosis and mortality. Cancer 1993; 71:517-23.Yancik, R. 2010. "Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis and mortality." Cancer 71 (S2): 517-523....
Screening for ovarian cancer: a pilot randomised controlled trial. Lancet. 1999;353(9160):1207-1210.PubMedGoogle ScholarCrossref 18. Pinsky PF, Yu K, Kramer BS, et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol Oncol...
aOvarian cancer has one of the highest mortality rates of all gynecologic malignant tumors. More than 70% of patients are late-stage at diagnosis [1], and the 5-year survival rate is approximately 19~40% [2-3]. Locoregional recurrence and distant metastases are ominous events in patients wi...
Increasing data suggest that aspirin use may improve cancer survival; however, the evidence is sparse for ovarian cancer. We examined the association between postdiagnosis use of low-dose aspirin and mortality in a nationwide cohort of women with epithel
Ovarian cancer (OC) can occur at different ages and is affected by a variety of factors. In order to evaluate the risk of cardiovascular mortality in patients with ovarian cancer, we included influencing factors including age, histological type, surgical method, chemotherapy, whether distant metastas...
The cancer mortality in Chinese cancer registration areas was 2.74/105,age standardized mortality rate by Chinese standard population and world standard population were 2.08/105 and 2.04/105 with the cumulative incidence(0~74 age years old) of 0.23%. The cancer mortality,ASR China and ASR world ...
METHODS: We evaluated secular changes in the incidence of breast, cervical and ovarian cancer in Mumbai women aged 30 – 64 between 1976 and 2005. Age-standardised incidence rates were calculated and presented by site and calendar period. An age – period – cohort (APC) analysis quantified ...
Results: Within two years after diagnosis, localized/regional-stage carcinosarcoma and distant-stage mucinous, clear cell, and carcinosarcoma had a higher risk of mortality compared with high-grade serous, with the most pronounced association for localized/regional carcinosarcoma (>1-2-year time...
Iceland had the highest age-adjusted ovarian cancer incidence in the Nordic countries, whereas Denmark had the highest mortality rate. In the entire period, the Danish mortality rate declined from 10.8 (1978-1982) to 9.0 per 100,000 woman-years (1998-1999). Only 19% of ovarian cancers in ...
Among the female relatives with BRCA1 or BRCA2 mutations, cumulative risk of developing either breast or ovarian cancer by age 60 and 80, respectively, were 0.60 (± 0.07) and 0.83 (± 0.07) for BRCA1 carriers and 0.33 (± 0.09) and 0.76 (± 0.13) for BRCA2 carriers. Risks were ...